XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Schedule of Intangible Assets

  

Website  $1,516 
Less website amortization   (348)
Customer list   664,237 
Intangible Assets   664,237 
Less Customer list amortization   (152,220)
Amortization   (152,220)
Net Intangible Assets  $513,185 
Schedule of Expected Amortization Expense of Intangible Assets

Expected amortization expense of intangible assets over the next 2 years is as follows:

 

Twelve Months ended June 30,

 

      
2024  $249,656 
2025   263,529 
Net Intangible Assets  $513,185 
Schedule of Disaggregation of Revenue

In the following table, revenue is disaggregated by primary geographical market, major product line, and timing of revenue recognition.

Schedule of Disaggregation of Revenue  

In thousands of US dollars ($)  Three Months Ended
June 30,
   Six Months Ended
June 30,
 
Primary geographical markets  2024   2023   2024   2023 
North America  $409   $261   $749   $816 
Europe   2    18    8    54 
Asia   11    233    14    382 
   $422   $512   $771   $1,252 

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
Major products/services lines  2024   2023   2024   2023 
Hardware  $105   $293   $188   $721 
Consumables   22    57    60    123 
Contract research services   7    31    7    36 
Sample preparation accessories   16    37    64    82 
Consumer Products   259    -    413    -  
Technical support/extended service contracts   11    46    31    89 
Agrochem Products   -    35    -    166 
Shipping and handling   2    8    8    27 
Other   -    5    -    8 
   $422   $512   $771   $1,252 

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
Timing of revenue recognition  2024   2023   2024   2023 
Products transferred at a point in time  $404   $435   $732   $1,127 
Services transferred over time   18    77    39    125 
   $422   $512   $771   $1,252 
Schedule of Contract Balances

Contract balances

  

In thousands of US dollars ($)  June 30, 2024   December 31, 2023 
Receivables, which are included in ‘Accounts Receivable’  $184   $151 
Contract liabilities (deferred revenue)   243    34 
Schedule of Future Related to Performance Obligations

The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period.

  

In thousands of US dollars ($)  2024   2025   Total 
Extended warranty service  $230   $13   $243 
Schedule of Customer Concentration Risk Percentage

The following table illustrates the level of concentration as a percentage of total revenues during the three and six months ended June 30, 2024 and 2023.

  

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2024   2023   2024   2023 
Top five customers   35%   70%   34%   55%
Federal agencies   1%   1%   1%   1%

 

The following table illustrates the level of concentration as a percentage of net accounts receivable balance as of June 30, 2024 and December 31, 2023. The Top Five Customers category may include federal agency receivable balances if applicable.

 

   June 30, 2024   December 31, 2023 
Top Five Customers   100%   96%
Schedule of Computation of Loss Per Share

The following table illustrates our computation of loss per share for the three and six months ended June 30, 2024 and 2023:

  

             
  

For the Three Months Ended

June 30,

  

For the Six Months Ended

June 30,

 
   2024   2023   2024   2023 
Numerator:                    
Net loss attributable to common shareholders  $(7,748,534)  $(11,114,925)  $(16,455,010)  $(18,404,566)
Denominator for basic and diluted loss per share:                    
Weighted average common stock shares outstanding   51,411,779    19,471,057    45,585,472    17,629,225 
Loss per common share - basic and diluted  $(0.15)  $(0.57)  $(0.36)  $(1.04)
Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings Per Share

  

         
   As of June 30, 
   2024   2023 
Stock options   14,825,266    3,420,754 
Convertible debt   10,520,985    7,058,298 
Common stock warrants   15,467,354    15,929,601 
Convertible preferred stock:          
Series D Convertible Preferred   6,250    6,250 
Series AA Convertible Preferred   8,645,000    8,601,000 
Series BB Convertible Preferred   28,540,000    3,620,000 
Series CC Convertible Preferred   4,010,000    4,010,000 
Series DD Convertible Preferred   2,540,000    - 
Total potentially dilutive shares    84,554,855    42,645,903 
Summary of Assumptions for the Grants of Stock Options

The following table summarizes the assumptions we utilized for grants of stock options to the three sub-groups of our stock option recipients during the six months ended June 30, 2024:

  

Assumptions  CEO, other Officers and Employees 
Expected life   6.0 (yrs.)
Expected volatility   151.7%
Risk-free interest rate   4.36%
Forfeiture rate   0 to 5.00% 
Expected dividend yield   0.0%
Schedule of Stock Based Compensation Expense

  

             
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2024   2023   2024   2023 
Cost of sales  $14,965   $11,060   $29,629   $64,541 
Research and development   48,960    35,289    92,217    205,909 
Selling and marketing   (12,790)   13,426    41,545    85,525 
Consumer Products   (6,188)   -    19,098    - 
General and administrative   105,081    75,779    207,831    1,209,823 
Total stock-based compensation expense  $150,028   $135,554   $390,320   $1,565,798 
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following tables set forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of June 30, 2024:

  

      

Fair value measurements at

June 30, 2024 using:

 
  

June 30,

2024

  

Quoted prices in active markets

(Level 1)

  

Significant other

observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

 
Equity Securities  $63,775   $63,775    -    - 
Total Financial Assets  $63,775   $63,775   $-   $- 

 

The following tables set forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2023:

 

      

Fair value measurements at

December 31, 2023 using:

 
  

December 31,

2023

  

Quoted prices in

active markets

(Level 1)

  

Significant other

observable inputs

(Level 2)

  

Significant

unobservable inputs

(Level 3)

 
Equity Securities   61,876    61,876     -    - 
Total Financial Assets  $61,876   $61,876   $-   $-